Recently, it was reported that upregulated miR-147b in EGFR mutant lung adenocarcinoma cells mediates drug tolerance to EGFR TKI osimertinib via repression of Von Hippel-Lindau (VHL) and succinate dehydrogenase (SDH) [102]. The gene discussed is EGFR; the disease is lung adenocarcinoma.